Enwei Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 200.8 million compared to CNY 157.6 million a year ago. Revenue was CNY 200.8 million compared to CNY 157.6 million a year ago.

Net income was CNY 27.67 million compared to CNY 20.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.3945 compared to CNY 0.3851 a year ago. Diluted earnings per share from continuing operations was CNY 0.3945 compared to CNY 0.3851 a year ago.